It was shown that the application of intermittent parathyroid hormone, an anabolic agent for bone, in combination with TNF inhibitor led to the significant repair of joint erosions in the TNF-transgenic murine models of RA [39], but not in established RA [40]. The gene discussed is TNF; the disease is rheumatoid arthritis.